Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
Conclusion
Multiple myeloma patients who received HDC/ASCT demonstrated a significant decrease in 18FDG uptake in the supratentorial brain and cerebellum, while patients who received CDC did not demonstrate significant changes in the brain 18FDG uptake.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Brain | Cerebellum | Chemotherapy | CT Scan | Myeloma | Neurology | Nuclear Medicine | PET Scan | Stem Cell Therapy | Stem Cells | Study | Transplants | Velcade